Oramed Pharmaceuticals Inc.
ORMPOramed Pharmaceuticals Inc. is a biotech company specializing in the development of oral drug delivery systems for diabetes and other conditions. Its flagship product aims to provide a non-invasive alternative to injectable medications by utilizing innovative oral protein delivery technology. The company focuses on advancing treatments for diabetes and other chronic diseases through its proprietary oral insulin and peptide formulations.
Dividend History
Investors can expect a dividend payout of $0.25 per share, scheduled to be distributed in 3 days on January 26, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 26, 2026 | $0.25 | 2026-01-16 | 2026-01-16 |
Dividends Summary
- Consistent Payer: Oramed Pharmaceuticals Inc. has rewarded shareholders with 1 dividend payments over the past 0 years.
- Total Returned Value: Investors who held ORMP shares during this period received a total of $0.25 per share in dividend income.
Company News
Oramed Pharmaceuticals received an $18 million payment from Scilex Holdings, closing out option agreement obligations and bringing total returns to $118 million on its original $99.5 million investment. The company's board approved a $0.25 per share cash dividend (~$10.5 million aggregate) to be paid on January 26, 2026. Oramed retains $39 millio...
Oramed Pharmaceuticals announced a Rights Plan to protect against hostile takeovers, distributing one common stock purchase right per outstanding share, with rights becoming exercisable if a person/group acquires 15% or more of outstanding stock.
Oramed Pharmaceuticals announced a joint venture with Hefei Tianhui Biotech to accelerate the development and commercialization of its oral insulin and other oral drug delivery technologies. The new company, OraTech Pharmaceuticals, will receive significant financial backing and leverage HTIT's manufacturing capabilities.
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, ...
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'. Conformis, Inc. (NASDAQ: CFMS) shares rose 91.3% to $0.2969 after the company agreed to be acquired by restor3d, a leading personalized 3D-printed orthopedic company, for a purchase price...
